The final chapter in genomic medicine

Tome Biosciences is the programmable gene insertion company. Using CRISPR, our technologies allow us to insert any genetic sequence of any size at any location into any genome. We are writing the final chapter in genomic medicines, delivering cures to patients through cell and genome engineering.

Join us and be part of the future of genomic medicines Open positions:

Tome openings Jan 2022.png

Tome Biosciences |One Kendall Square | Building 200, Suite 001 |Cambridge, MA 02139 |

In addition to the positions above, we are seeking clinicians, clinician-scientists and drug development professionals with deep therapeutic area expertise in hepatic / metabolic diseases and oncology to drive our clinical strategy. If interested, please apply to the email above.